GlassScriptPhysician profile
Elsayed Abo-Salem
NPI 1629207477
$27,946.80
in general payments reported to CMS, 2019-2025
32 companies · $2,417 in 2025
The $2,417 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,476 · 2020: $2,654 · 2021: $1,295 · 2022: $8,177 · 2023: $3,542 · 2024: $4,387 · 2025: $2,417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,017 · Travel and Lodging: $2,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,017.27 |
| Travel and Lodging | $2,328.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $12,163.83 | 2019-2022 | |
| Abbott Laboratories | $3,920.60 | 2020-2025 | Amplatzer Amulet, Mitraclip, Jot Dx |
| Abiomed | $3,365.10 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $2,546.77 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Cardiovascular Systems INC. | $1,275.83 | 2019-2021 | |
| Shockwave Medical, INC | $727.95 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $476.40 | 2021-2025 | Corevalve Evolut R, Linq II |
| Amgen INC. | $444.29 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $373.10 | 2019-2025 | Avvigo Guidance System, Synergy, Rotablator Rotational Atherectomy System Console Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $344.15 | 2022-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $333.21 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $283.59 | 2022-2024 | Verquvo |
| Pfizer INC. | $236.35 | 2023-2025 | |
| Penumbra, INC. | $195.00 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.23 | 2022-2024 | Jardiance |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $147.17 | 2023-2025 | Kengreal, Cleviprex |
| Cvrx, INC. | $135.74 | 2024 | Barostim Neo System |
| Medtronic Vascular, INC. | $124.53 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $117.20 | 2023-2024 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $111.64 | 2022-2024 | |
| Novo Nordisk INC | $69.19 | 2024-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $67.96 | 2022-2024 | Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $64.40 | 2022-2024 | Xarelto |
| Kiniksa Pharmaceuticals, LTD. | $52.03 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $45.81 | 2022-2025 | |
| Esperion Therapeutics, INC. | $32.66 | 2022-2023 | Nexletol |
| Biosense Webster, INC. | $24.07 | 2024 | Na |
| Alnylam Pharmaceuticals INC. | $21.31 | 2025 | Amvuttra |
| Vifor Pharma, INC. | $20.79 | 2022 | |
| Teleflex LLC | $20.43 | 2025 | |
| Impulse Dynamics (USA) INC. | $15.83 | 2022 | |
| Heartflow, INC. | $15.64 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elsayed Abo-Salem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.